524. SURVIVAL AFTER CURATIVELY INTENDED TREATMENT OF ESOPHAGEAL CANCER IN THE NORDIC COUNTRIES Free

Esophageal cancer is the 6th leading cause of cancer related death and has a high impact on life quality. With the ambition to improve long-term survival multimodal treatment including chemotherapy, or combined chemoradiotherapy, followed by surgical resection has become the standard of care. The overall aim of this study is to demonstrate the current treatment of esophageal cancer and survival in the Nordic countries.

In this cohort study based on prospective national patient registers all patients with esophageal cancer treated with curative intent between 2015-2020 in Sweden, Denmark, Norway, Finland and Island were included. Primary endpoint is 1-year survival after curative treatment for esophageal cancer. Secondary outcome is to describe curative intended treatment for esophageal cancer in the Nordic countries.

The results will describe baseline characteristics, curative treatment including details of the surgical and perioperative treatment, and survival stratified by country.

The conclusion will describe the current curative treatment of esophageal cancer in the Nordic countries.